Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapy.
作者信息
Clark C Amos, Mosse Claudio A, Chen Heidi, Byrne Michael, Chinratanalab Wichai, Engelhardt Brian G, Goodman Stacey A, Harrell Shelton L, Kassim Adetola A, Savani Bipin N, Sengsayadeth Salyka, Jagasia Madan, Cornell R Frank
机构信息
Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Department of Hematopathology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
出版信息
Bone Marrow Transplant. 2018 Dec;53(12):1589-1592. doi: 10.1038/s41409-018-0241-2. Epub 2018 Jun 18.
PMID:29915217
Abstract
摘要
Zotero 插件